The Medicines and Healthcare products Regulatory Agency has released updated data categorising the status of all medical device exemptions granted under exceptional use authorisations, including active exemptions, time-limited authorisations, and withdrawn authorisations. This comprehensive documentation provides healthcare systems with essential regulatory intelligence for device procurement and clinical implementation decisions. The registry captures devices across multiple therapeutic and diagnostic categories, offering a complete picture of emergency regulatory pathways currently active or recently concluded. By publishing this detailed status information, the MHRA enables transparency that supports informed clinical governance and procurement planning. Healthcare providers can now systematically verify exemption status before integrating devices into clinical workflows, reducing implementation risks during health emergencies. The availability of both current and historical exemption data enhances the evidence base for understanding how emergency regulatory mechanisms function in practice. Read the full article on GMJ Newsroom.
Was this article helpful?
